Canadian guidelines for hereditary transthyretin amyloidosis polyneuropathy management
M Alcantara, MM Mezei, SK Baker, A Breiner… - Canadian Journal of …, 2022 - cambridge.org
… transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients
with hereditary and wild-type transthyretin amyloidosis… Hereditary transthyretin amyloidosis: …
with hereditary and wild-type transthyretin amyloidosis… Hereditary transthyretin amyloidosis: …
EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis
Z Bashir, A Younus, S Dhillon, A Kasi… - Journal of …, 2024 - journals.sagepub.com
… Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection …
Early-onset val30met transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey …
Early-onset val30met transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey …
Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years
J Wixner, OB Suhr, I Anan - Expert Review of Gastroenterology & …, 2018 - Taylor & Francis
… Hereditary transthyretin amyloidosis (ATTRm amyloidosis) is a rare disease that affects
approximately 1 in every 100,000 individuals [Citation1]. It is one of the most common …
approximately 1 in every 100,000 individuals [Citation1]. It is one of the most common …
[HTML][HTML] Advances in the Diagnosis and Management of Cardiac Amyloidosis: A Literature Review
J Llerena-Velastegui… - Cardiology …, 2024 - ncbi.nlm.nih.gov
… transthyretin amyloidosis, which includes wild-type (wild-type … Additionally, novel diagnostic
tools like bone scintigraphy … specificity for detecting transthyretin amyloidosis, further aiding …
tools like bone scintigraphy … specificity for detecting transthyretin amyloidosis, further aiding …
Cardiac amyloidosis due to transthyretin protein: a review
FL Ruberg, MS Maurer - JAMA, 2024 - jamanetwork.com
… features of ATTR amyloidosis, noninvasive diagnosis can be accomplished using nuclear
… Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the …
… Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the …
[HTML][HTML] AL amyloidosis: advances in diagnosis and management
Y Koh - Blood research, 2020 - synapse.koreamed.org
… involvement is the most critical part of the diagnosis. Recent advances in imaging techniques
have contributed to the logical diagnostic procedure of determining heart involvement. …
have contributed to the logical diagnostic procedure of determining heart involvement. …
Transthyretin amyloid cardiomyopathy
P Garcia-Pavia, F Domínguez… - Medicina Clínica (English …, 2021 - Elsevier
… with left ventricular hypertrophy should lead to consideration of transthyretin amyloidosis. …
and negatives in diphosphonate scintigraphy in the diagnosis of transthyretin amyloidosis. …
and negatives in diphosphonate scintigraphy in the diagnosis of transthyretin amyloidosis. …
CNS involvement in hereditary transthyretin amyloidosis
… Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is predominantly a disease of
the peripheral nerves, heart, kidney, and eye. CNS involvement has been a marginal issue in …
the peripheral nerves, heart, kidney, and eye. CNS involvement has been a marginal issue in …
Pathway for the Diagnosis and Management of Cardiac Amyloidosis
E Herzog, D Leibowitz, ME Gatt, T Koren… - Critical Pathways in …, 2023 - journals.lww.com
… Transthyretin amyloidosis with concomitant monoclonal gammopathy of unknown significance
(or any hematological disorder that produces FLC), AL amyloidosis, or coexistence of …
(or any hematological disorder that produces FLC), AL amyloidosis, or coexistence of …
Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
… the amyloid precursor proteins causing a very heterogeneous disease spectrum, but the
main types of amyloidosis involving the heart are light chain (AL) and transthyretin amyloidosis (…
main types of amyloidosis involving the heart are light chain (AL) and transthyretin amyloidosis (…